Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Plans Dividend Increase – $0.11 Per Share

Posted by Jessica Moore on Dec 21st, 2024

Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) declared a quarterly dividend on Friday, December 20th,NASDAQ Dividends reports. Stockholders of record on Friday, December 20th will be given a dividend of 0.112 per share on Tuesday, December 24th. This represents a $0.45 annualized dividend and a dividend yield of 1.79%. The ex-dividend date is Friday, December 20th. This is an increase from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.001.

Fidelity Disruptive Medicine ETF Price Performance

Shares of NASDAQ FMED opened at $25.03 on Friday. Fidelity Disruptive Medicine ETF has a 1-year low of $23.22 and a 1-year high of $26.68. The business’s fifty day moving average price is $25.84 and its two-hundred day moving average price is $25.31. The firm has a market capitalization of $52.56 million, a PE ratio of 35.73 and a beta of 0.94.

About Fidelity Disruptive Medicine ETF

(Get Free Report)

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.